PBM Stock Price | Psyence Biomedical Ltd. Common Shares P/E, Revenue, EPS, & Forecasts

Psyence Biomedical Ltd. Common Shares • PBM

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Psyence Biomedical Ltd. Common Shares

Ticker

PBM

Trading on

NASDAQ

ISIN

CA74449F4078

Industry

Biotechnology

Sector

Healthcare

CEO

Jody Aufrichtig

Headquarters

121 Richmond Street West, Toronto, ON, Canada, M5H 2K1

Employees

Website

https://psyencebiomed.com

Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.

Metrics

BasicAdvanced

Market cap

$15.8M

P/E ratio

EPS

-$12.56

Dividend Yield

0.00%

Beta

1.69

Forward P/E ratio

EBIDTA

$-6.2M

Ex dividend date

Price & volume

Market cap

$15.8M

Average daily volume

0.1M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

1.42

Earnings

EPS

-$12.56

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-6.2M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

1.69

52-week High

$22.25

52-week Low

$1.92

50-day moving average

$4.76

200-day moving average

$5.81

Short ratio

0.31

Short %

1.01%

Management effectiveness

ROE (TTM)

-58.62%

ROA (TTM)

-31.33%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

3.8M

Float

2.6M

Insiders %

2.97%

Institutions %

13.24%

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

$0.04

Q3 • 24Beat

$4.06

Q4 • 24Beat

-$99.97

Q1 • 25Beat

-$0.51

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0.1M

0.00%

Q4 • 24

$0M

$-0.8M

-∞%

Q3 • 25

NaN%

-632.44%

0.00%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$2.3M

$3.5M

155.70%

Q4 • 24

$12.8M

$0.9M

7.36%

Q3 • 25

468.46%

-73.12%

-95.27%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

Q3 • 24

Q3 • 25

NaN%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Psyence Biomedical Ltd. Common Shares share?

Psyence Biomedical Ltd. Common Shares shares are currently traded for undefined per share.

How many shares does Psyence Biomedical Ltd. Common Shares have?

Psyence Biomedical Ltd. Common Shares currently has 3.8M shares.

Does Psyence Biomedical Ltd. Common Shares pay dividends?

No, Psyence Biomedical Ltd. Common Shares doesn't pay dividends.

What is Psyence Biomedical Ltd. Common Shares 52 week high?

Psyence Biomedical Ltd. Common Shares 52 week high is $22.25.

What is Psyence Biomedical Ltd. Common Shares 52 week low?

Psyence Biomedical Ltd. Common Shares 52 week low is $1.92.

What is the 200-day moving average of Psyence Biomedical Ltd. Common Shares?

Psyence Biomedical Ltd. Common Shares 200-day moving average is $5.81.

Who is Psyence Biomedical Ltd. Common Shares CEO?

The CEO of Psyence Biomedical Ltd. Common Shares is Jody Aufrichtig.

How many employees Psyence Biomedical Ltd. Common Shares has?

Psyence Biomedical Ltd. Common Shares has 12 employees.

What is the market cap of Psyence Biomedical Ltd. Common Shares?

The market cap of Psyence Biomedical Ltd. Common Shares is $15.8M.

What is the P/E of Psyence Biomedical Ltd. Common Shares?

The current P/E of Psyence Biomedical Ltd. Common Shares is null.

What is the EPS of Psyence Biomedical Ltd. Common Shares?

The EPS of Psyence Biomedical Ltd. Common Shares is -$12.56.

What is the PEG Ratio of Psyence Biomedical Ltd. Common Shares?

The PEG Ratio of Psyence Biomedical Ltd. Common Shares is null.